ITGA2B and coronary artery disorder: The exposure of activated GP IIb-IIIa and P selectin in response to the same agonists (TRAP 10 μM, and ADP 20, 5 μM) was expectedly lower in the CHD and ACS groups in comparison with the control group due to the applied antiplatelet therapy (all differences were significant except for TRAP 10 μM, CD62P+, % in the CHD group) (Figure 1 and Table 2).